[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Jaffer et al., 2006 - Google Patents

Molecular imaging of myocardial infarction

Jaffer et al., 2006

Document ID
2457044969561044161
Author
Jaffer F
Sosnovik D
Nahrendorf M
Weissleder R
Publication year
Publication venue
Journal of molecular and cellular cardiology

External Links

Snippet

Molecular tools are rapidly elucidating the molecular and cellular processes underlying myocardial infarction. To further understand these biological processes in vivo, investigators are embracing the burgeoning field of molecular imaging. Here we review important aspects …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Nahrendorf et al. Multimodality cardiovascular molecular imaging, Part II
Jaffer et al. Molecular imaging of myocardial infarction
Jaffer et al. Seeing within: molecular imaging of the cardiovascular system
Cai et al. How molecular imaging is speeding up antiangiogenic drug development
Dobrucki Imaging angiogenesis
Hsu et al. In vivo near-infrared fluorescence imaging of integrin α v β 3 in an orthotopic glioblastoma model
Frangioni et al. In vivo tracking of stem cells for clinical trials in cardiovascular disease
Jaffer et al. Molecular imaging of cardiovascular disease
Zhou et al. Imaging stem cells implanted in infarcted myocardium
Wu et al. Molecular imaging of cardiovascular gene products
Cai et al. Multimodality tumor imaging targeting integrin αvβ3
Leong-Poi Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy
Rodriguez-Porcel In vivo imaging and monitoring of transplanted stem cells: clinical applications
Liu et al. Noninvasive imaging of CCR2+ cells in ischemia-reperfusion injury after lung transplantation
Räty et al. Non-invasive imaging in gene therapy
Korngold et al. Noninvasive imaging of apoptosis in cardiovascular disease
Volpe et al. Cousins at work: how combining medical with optical imaging enhances in vivo cell tracking
Hoshino et al. In vivo tracking in cardiac stem cell-based therapy
Smith et al. Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis
Mandic et al. Molecular imaging of angiogenesis in cardiac regeneration
Lindner et al. Molecular imaging in cardiovascular disease: Which methods, which diseases?
Liang et al. Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle
Rome et al. Gene expression and gene therapy imaging
McCarthy Nanomedicine and cardiovascular disease
Dobrucki et al. Cardiovascular molecular imaging